158 related articles for article (PubMed ID: 34817796)
21. Assessment of neurocognitive function in association with WHO grades in gliomas.
Yamawaki R; Nankaku M; Umaba C; Ueda M; Liang N; Mineharu Y; Yamao Y; Ikeguchi R; Matsuda S; Miyamoto S; Arakawa Y
Clin Neurol Neurosurg; 2021 Sep; 208():106824. PubMed ID: 34329808
[TBL] [Abstract][Full Text] [Related]
22. Perioperative Neurocognitive Function in Glioma Surgery.
Noll KR; Bradshaw M; Sheppard D; Wefel JS
Curr Oncol Rep; 2024 May; 26(5):466-476. PubMed ID: 38573439
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal cognitive follow-up in low grade gliomas.
Correa DD; Shi W; Thaler HT; Cheung AM; DeAngelis LM; Abrey LE
J Neurooncol; 2008 Feb; 86(3):321-7. PubMed ID: 17926007
[TBL] [Abstract][Full Text] [Related]
24. Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825).
Wefel JS; Armstrong TS; Pugh SL; Gilbert MR; Wendland MM; Brachman DG; Roof KS; Brown PD; Crocker IR; Robins HI; Hunter G; Won M; Mehta MP
Neuro Oncol; 2021 Jul; 23(7):1125-1138. PubMed ID: 33515019
[TBL] [Abstract][Full Text] [Related]
25. Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab.
Wefel JS; Cloughesy T; Zazzali JL; Zheng M; Prados M; Wen PY; Mikkelsen T; Schiff D; Abrey LE; Yung WK; Paleologos N; Nicholas MK; Jensen R; Vredenburgh J; Das A; Friedman HS
Neuro Oncol; 2011 Jun; 13(6):660-8. PubMed ID: 21558074
[TBL] [Abstract][Full Text] [Related]
26. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis.
Li J; Bentzen SM; Li J; Renschler M; Mehta MP
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):64-70. PubMed ID: 18406884
[TBL] [Abstract][Full Text] [Related]
27. Clinical relevance of the radiation dose bath in lower grade glioma, a cross-sectional pilot study on neurocognitive and radiological outcome.
van der Weide HL; Kłos J; Langendijk JA; Brouwer CL; Sinnige PF; Borra RJH; Dierckx RAJO; Huitema RB; Rakers SE; Buunk AM; Spikman JM; Bosma IB; Enting RH; Blandhol M; Chiu RK; van der Hoorn A; Kramer MCA
Clin Transl Radiat Oncol; 2022 Mar; 33():99-105. PubMed ID: 35198742
[TBL] [Abstract][Full Text] [Related]
28. Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers: A longitudinal study spanning two decades.
Boele FW; den Otter PWM; Reijneveld JC; de Witt Hamer PC; van Thuijl HF; Lorenz LMC; Wesseling P; Lagerwaard FJ; Taphoorn MJB; Kouwenhoven MCM; Snijders TJ; Douw L; Klein M
Neuro Oncol; 2023 Feb; 25(2):351-364. PubMed ID: 35908832
[TBL] [Abstract][Full Text] [Related]
29. The course of neurocognitive functioning in high-grade glioma patients.
Bosma I; Vos MJ; Heimans JJ; Taphoorn MJ; Aaronson NK; Postma TJ; van der Ploeg HM; Muller M; Vandertop WP; Slotman BJ; Klein M
Neuro Oncol; 2007 Jan; 9(1):53-62. PubMed ID: 17018697
[TBL] [Abstract][Full Text] [Related]
30. "A prospective study of assessment of neurocognitive function in illiterate patients with gliomas treated with chemoradiation": Assessment of neurocognitive function in gliomas.
Valiyaveettil D; G A; Malik M; Eaga P; Ahmed SF; Joseph D
Cancer Treat Res Commun; 2021; 26():100288. PubMed ID: 33352469
[TBL] [Abstract][Full Text] [Related]
31. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function.
Li J; Bentzen SM; Renschler M; Mehta MP
J Clin Oncol; 2007 Apr; 25(10):1260-6. PubMed ID: 17401015
[TBL] [Abstract][Full Text] [Related]
32. Effects of surgery on neurocognitive function in patients with glioma: a meta-analysis of immediate post-operative and long-term follow-up neurocognitive outcomes.
Ng JCH; See AAQ; Ang TY; Tan LYR; Ang BT; King NKK
J Neurooncol; 2019 Jan; 141(1):167-182. PubMed ID: 30446902
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of DNA repair genes and risk of glioma.
Wang LE; Bondy ML; Shen H; El-Zein R; Aldape K; Cao Y; Pudavalli V; Levin VA; Yung WK; Wei Q
Cancer Res; 2004 Aug; 64(16):5560-3. PubMed ID: 15313891
[TBL] [Abstract][Full Text] [Related]
34. Neuropsychological performances in patients with infiltrative non-GBM gliomas after postoperative adjuvant photon or proton radiotherapy: A prospective and preliminary investigation.
Lin SY; Chuang CC; Huang YC; Pai PC; Lee CC; Wei KC; Tseng CK; Yang CC
Appl Neuropsychol Adult; 2022 Mar; ():1-10. PubMed ID: 35343323
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal study of cognitive function in glioma patients treated with modern radiotherapy techniques and standard chemotherapy.
Rydelius A; Lätt J; Kinhult S; Engelholm S; Van Westen D; Pihlsgård M; Bengzon J; Sundgren PC; Lilja Å
Acta Oncol; 2020 Sep; 59(9):1091-1097. PubMed ID: 32847475
[No Abstract] [Full Text] [Related]
36. Changes in functional brain networks and neurocognitive function in Chinese gynecological cancer patients after chemotherapy: a prospective longitudinal study.
Zeng Y; Cheng ASK; Song T; Sheng X; Cheng H; Qiu Y; Xie J; Chan CCH
BMC Cancer; 2019 Apr; 19(1):386. PubMed ID: 31023249
[TBL] [Abstract][Full Text] [Related]
37. Multidomain and long-term cognitive evaluation in malignant glioma patients.
Tanzilli A; Pace A; Prosperini L; Oppido PA; Telera S; Rasile F; Farneti A; Marucci L; Villani V
Future Oncol; 2022 May; 18(15):1839-1848. PubMed ID: 35196869
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the impact of hippocampal sparing during whole brain radiotherapy on neurocognitive functions: A preliminary report of a prospective phase II study.
Lin SY; Yang CC; Wu YM; Tseng CK; Wei KC; Chu YC; Hsieh HY; Wu TH; Pai PC; Hsu PW; Chuang CC
Biomed J; 2015; 38(5):439-49. PubMed ID: 25994802
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma.
Bethke L; Webb E; Murray A; Schoemaker M; Johansen C; Christensen HC; Muir K; McKinney P; Hepworth S; Dimitropoulou P; Lophatananon A; Feychting M; Lönn S; Ahlbom A; Malmer B; Henriksson R; Auvinen A; Kiuru A; Salminen T; Swerdlow A; Houlston R
Hum Mol Genet; 2008 Mar; 17(6):800-5. PubMed ID: 18048407
[TBL] [Abstract][Full Text] [Related]
40. Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes.
Hall WA; Pugh SL; Wefel JS; Armstrong TS; Gilbert MR; Brachman DG; Werner-Wasik M; Wendland MM; Brown PD; Chao ST; Roof KS; Robins HI; Mehta MP; Curran WJ; Movsas B
Neurosurgery; 2019 Jan; 84(1):66-76. PubMed ID: 29618054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
